The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiba, K.
Right arrow Articles by Hoshino, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiba, K.
Right arrow Articles by Hoshino, Y.
The Journal of Immunology, 1998, 160: 5037-5044.
Copyright © 1998 by The American Association of Immunologists

FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats. I. FTY720 Selectively Decreases the Number of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing

Kenji Chiba1, Yoshiki Yanagawa, Yumi Masubuchi, Hirotoshi Kataoka, Takafumi Kawaguchi, Makio Ohtsuki and Yukio Hoshino

Research Laboratories, Yoshitomi Pharmaceutical Industries, Limited,Iruma, Saitama, Japan

FTY720, given i.v. or orally at 0.03 mg/kg or more, significantly prolonged skin allograft survival in a dose-dependent manner and showed more potent immunosuppressive activity than cyclosporin A (CsA) or tacrolimus (FK506) in MHC-incompatible rat strains of WKAH donors and F344 recipients. However, unlike CsA or FK506, FTY720 up to 1000 nM did not affect IL-2 production in allogeneic MLC. Within 3 to 24 h after a single oral administration of FTY720 at 0.1 to 1 mg/kg, the number of lymphocytes in the rats was markedly decreased in the peripheral blood and thoracic duct lymph and partially in spleen. By contrast, the number of lymphocytes in peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer’s patches (PP) was significantly increased at the same time. Intravenous transfusion of calcein-labeled rat lymphocytes into rats revealed that FTY720 significantly accelerated lymphocyte homing to PLN, MLN, and PP, dose dependently. Since FTY720-induced lymphocyte homing was completely blocked by simultaneous treatment of the calcein-labeled lymphocytes with mAbs against CD62L, CD49d, and CD11a before the transfusion, the acceleration of lymphocyte homing by FTY720 appears to be mediated by lymphocyte-homing receptors. These findings indicate that FTY720 sequesters circulating mature lymphocytes into PLN, MLN, and PP by acceleration of lymphocyte homing and thereby decreases the number of lymphocytes in peripheral blood, thoracic duct lymph, and spleen. Based on these observations, sequestration of circulating mature-lymphocytes is presumed to be a main mechanism of the immunosuppressive activity of FTY720.




This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
B. J. E. Raveney, D. A. Copland, L. B. Nicholson, and A. D. Dick
Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory Disease
Arch Ophthalmol, October 1, 2008; 126(10): 1390 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Weinreich and K. A. Hogquist
Thymic Emigration: When and How T Cells Leave Home
J. Immunol., August 15, 2008; 181(4): 2265 - 2270.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Tomura, N. Yoshida, J. Tanaka, S. Karasawa, Y. Miwa, A. Miyawaki, and O. Kanagawa
Monitoring cellular movement in vivo with photoconvertible fluorescence protein "Kaede" transgenic mice
PNAS, August 5, 2008; 105(31): 10871 - 10876.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
B. Metzler, P. Gfeller, G. Wieczorek, J. Li, B. Nuesslein-Hildesheim, A. Katopodis, M. Mueller, and V. Brinkmann
Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure
Int. Immunol., May 1, 2008; 20(5): 633 - 644.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
G. Saab, A. Almony, K. J. Blinder, R. Schuessler, and D. C. Brennan
Reversible Cystoid Macular Edema Secondary to Fingolimod in a Renal Transplant Recipient
Arch Ophthalmol, January 1, 2008; 126(1): 140 - 141.
[Full Text] [PDF]

Home page
 FASEB J.Home page
M. L. Allende, D. Zhou, D. N. Kalkofen, S. Benhamed, G. Tuymetova, C. Borowski, A. Bendelac, and R. L. Proia
S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues
FASEB J, January 1, 2008; 22(1): 307 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Kim, M. Kim, N. Kim, V. D. D'Agati, C. W. Emala Sr, and H. T. Lee
Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1827 - F1835.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. P. Coelho, S. G. Payne, R. Bittman, S. Spiegel, and C. Sato-Bigbee
The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 626 - 635.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. Kunisawa, Y. Kurashima, M. Higuchi, M. Gohda, I. Ishikawa, I. Ogahara, N. Kim, M. Shimizu, and H. Kiyono
Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium
J. Exp. Med., October 1, 2007; 204(10): 2335 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Huang, L. I. Cardenas-Navia, C. C. Caldwell, T. J. Plumb, C. G. Radu, P. N. Rocha, T. Wilder, J. S. Bromberg, B. N. Cronstein, M. Sitkovsky, et al.
Requirements for T Lymphocyte Migration in Explanted Lymph Nodes
J. Immunol., June 15, 2007; 178(12): 7747 - 7755.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Kunisawa, Y. Kurashima, M. Gohda, M. Higuchi, I. Ishikawa, F. Miura, I. Ogahara, and H. Kiyono
Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production
Blood, May 1, 2007; 109(9): 3749 - 3756.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Maeda, H. Matsuyuki, K. Shimano, H. Kataoka, K. Sugahara, and K. Chiba
Migration of CD4 T Cells and Dendritic Cells toward Sphingosine 1-Phosphate (S1P) Is Mediated by Different Receptor Subtypes: S1P Regulates the Functions of Murine Mature Dendritic Cells via S1P Receptor Type 3
J. Immunol., March 15, 2007; 178(6): 3437 - 3446.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Q. Deng, J. A. Clemas, G. Chrebet, P. Fischer, J. J. Hale, Z. Li, S. G. Mills, J. Bergstrom, S. Mandala, R. Mosley, et al.
Identification of Leu276 of the S1P1 Receptor and Phe263 of the S1P3 Receptor in Interaction with Receptor Specific Agonists by Molecular Modeling, Site-Directed Mutagenesis, and Affinity Studies
Mol. Pharmacol., March 1, 2007; 71(3): 724 - 735.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Daniel, N. Sartory, N. Zahn, G. Geisslinger, H. H. Radeke, and J. M. Stein
FTY720 Ameliorates Th1-Mediated Colitis in Mice by Directly Affecting the Functional Activity of CD4+CD25+ Regulatory T Cells
J. Immunol., February 15, 2007; 178(4): 2458 - 2468.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Yasuda, T. Kuwabara, H. Nakano, K. Aritomi, T. Onodera, M. Lipp, Y. Takahama, and T. Kakiuchi
Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells
Blood, January 15, 2007; 109(2): 449 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. D. Keller, P. Rivera Gil, M. Tolle, M. van der Giet, J. Chun, H. H. Radeke, M. Schafer-Korting, and B. Kleuser
Immunomodulator FTY720 Induces Myofibroblast Differentiation via the Lysophospholipid Receptor S1P3 and Smad3 Signaling
Am. J. Pathol., January 1, 2007; 170(1): 281 - 292.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Kabashima, N. M. Haynes, Y. Xu, S. L. Nutt, M. L. Allende, R. L. Proia, and J. G. Cyster
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism
J. Exp. Med., November 27, 2006; 203(12): 2683 - 2690.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
G. M. L. Meno-Tetang, H. Li, S. Mis, N. Pyszczynski, P. Heining, P. Lowe, and W. J. Jusko
Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous Doses
Drug Metab. Dispos., September 1, 2006; 34(9): 1480 - 1487.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
R. Schmouder, D. Serra, Y. Wang, J. M. Kovarik, J. DiMarco, T. L. Hunt, and M.-C. Bastien
FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects.
J. Clin. Pharmacol., August 1, 2006; 46(8): 895 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Fujii, T. Kanai, Y. Nemoto, S. Makita, S. Oshima, R. Okamoto, K. Tsuchiya, T. Totsuka, and M. Watanabe
FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis
Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G267 - G274.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Zemann, B. Kinzel, M. Muller, R. Reuschel, D. Mechtcheriakova, N. Urtz, F. Bornancin, T. Baumruker, and A. Billich
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Blood, February 15, 2006; 107(4): 1454 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Sawicka, G. Dubois, G. Jarai, M. Edwards, M. Thomas, A. Nicholls, R. Albert, C. Newson, V. Brinkmann, and C. Walker
The Sphingosine 1-Phosphate Receptor Agonist FTY720 Differentially Affects the Sequestration of CD4+/CD25+ T-Regulatory Cells and Enhances Their Functional Activity
J. Immunol., December 15, 2005; 175(12): 7973 - 7980.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. I. Singer, M. Tian, L. A. Wickham, J. Lin, S. S. Matheravidathu, M. J. Forrest, S. Mandala, and E. J. Quackenbush
Sphingosine-1-Phosphate Agonists Increase Macrophage Homing, Lymphocyte Contacts, and Endothelial Junctional Complex Formation in Murine Lymph Nodes
J. Immunol., December 1, 2005; 175(11): 7151 - 7161.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kharel, S. Lee, A. H. Snyder, S. L. Sheasley-O'Neill, M. A. Morris, Y. Setiady, R. Zhu, M. A. Zigler, T. L. Burcin, K. Ley, et al.
Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720
J. Biol. Chem., November 4, 2005; 280(44): 36865 - 36872.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Bandhuvula, Y. Y. Tam, B. Oskouian, and J. D. Saba
The Immune Modulator FTY720 Inhibits Sphingosine-1-phosphate Lyase Activity
J. Biol. Chem., October 7, 2005; 280(40): 33697 - 33700.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
B. R Blazar and W. J Murphy
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)
Phil Trans R Soc B, September 29, 2005; 360(1461): 1747 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Halin, M. L. Scimone, R. Bonasio, J.-M. Gauguet, T. R. Mempel, E. Quackenbush, R. L. Proia, S. Mandala, and U. H. von Andrian
The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches
Blood, August 15, 2005; 106(4): 1314 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. A. Vora, E. Nichols, G. Porter, Y. Cui, C. A. Keohane, R. Hajdu, J. Hale, W. Neway, D. Zaller, and S. Mandala
Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement
J. Leukoc. Biol., August 1, 2005; 78(2): 471 - 480.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Davis, J. J. Clemens, T. L. Macdonald, and K. R. Lynch
Sphingosine 1-Phosphate Analogs as Receptor Antagonists
J. Biol. Chem., March 18, 2005; 280(11): 9833 - 9841.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. G. Lo, Y. Xu, R. L. Proia, and J. G. Cyster
Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit
J. Exp. Med., January 18, 2005; 201(2): 291 - 301.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Han, X. Zhang, G. Wang, H. Guan, G. Garcia, P. Li, L. Feng, and B. Zheng
FTY720 suppresses humoral immunity by inhibiting germinal center reaction
Blood, December 15, 2004; 104(13): 4129 - 4133.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Allende, T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten-Deckert, R. Hajdu, M. Rosenbach, C. A. Keohane, S. Mandala, et al.
Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720
J. Biol. Chem., December 10, 2004; 279(50): 52487 - 52492.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
U. Kunzendorf, E. Ziegler, and D. Kabelitz
FTY720--the first compound of a new promising class of immunosuppressive drugs
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1677 - 1681.
[Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
K Mayer, F Birnbaum, T Reinhard, A Reis, S Braunstein, F Claas, and R Sundmacher
FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations
Br. J. Ophthalmol., July 1, 2004; 88(7): 915 - 919.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Kimura, A. M. Boehmler, G. Seitz, S. Kuci, T. Wiesner, V. Brinkmann, L. Kanz, and R. Mohle
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells
Blood, June 15, 2004; 103(12): 4478 - 4486.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Forrest, S.-Y. Sun, R. Hajdu, J. Bergstrom, D. Card, G. Doherty, J. Hale, C. Keohane, C. Meyers, J. Milligan, et al.
Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 758 - 768.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Allende, J. L. Dreier, S. Mandala, and R. L. Proia
Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration
J. Biol. Chem., April 9, 2004; 279(15): 15396 - 15401.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Bohler, J. Waiser, M. Schuetz, H. H. Neumayer, and K. Budde
FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors
Nephrol. Dial. Transplant., March 1, 2004; 19(3): 702 - 713.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Sawicka, C. Zuany-Amorim, C. Manlius, A. Trifilieff, V. Brinkmann, D. M. Kemeny, and C. Walker
Inhibition of Th1- and Th2-Mediated Airway Inflammation by the Sphingosine 1-Phosphate Receptor Agonist FTY720
J. Immunol., December 1, 2003; 171(11): 6206 - 6214.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Billich, F. Bornancin, P. Devay, D. Mechtcheriakova, N. Urtz, and T. Baumruker
Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases
J. Biol. Chem., November 28, 2003; 278(48): 47408 - 47415.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Welsch, S. Hagiwara, J. F. Goetschy, and N. R. Movva
Ubiquitin Pathway Proteins Influence the Mechanism of Action of the Novel Immunosuppressive Drug FTY720 in Saccharomyces cerevisiae
J. Biol. Chem., July 11, 2003; 278(29): 26976 - 26982.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. C. Yopp, G. J. Randolph, and J. S. Bromberg
Leukotrienes, Sphingolipids, and Leukocyte Trafficking
J. Immunol., July 1, 2003; 171(1): 5 - 10.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. S. Gridley, G. A. Nelson, L. L. Peters, P. J. Kostenuik, T. A. Bateman, S. Morony, L. S. Stodieck, D. L. Lacey, S. J. Simske, and M. J. Pecaut
Genetic Models in Applied Physiology: Selected Contribution: Effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets
J Appl Physiol, May 1, 2003; 94(5): 2095 - 2103.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Fujino, N. Funeshima, Y. Kitazawa, H. Kimura, H. Amemiya, S. Suzuki, and X.-K. Li
Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 70 - 77.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. H. Xie, N. Nomura, S. L. Koprak, E. J. Quackenbush, M. J. Forrest, and H. Rosen
Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells
J. Immunol., April 1, 2003; 170(7): 3662 - 3670.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Brinkmann, M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al.
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
J. Biol. Chem., June 7, 2002; 277(24): 21453 - 21457.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Li, G. M. L. Meno-Tetang, K. Chiba, N. Arima, P. Heining, and W. J. Jusko
Pharmacokinetics and Cell Trafficking Dynamics of 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol Hydrochloride (FTY720) in Cynomolgus Monkeys after Single Oral and Intravenous Doses
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 519 - 526.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Budde, R. L. Schmouder, R. Brunkhorst, B. Nashan, P. W. Lucker, T. Mayer, S. Choudhury, A. Skerjanec, G. Kraus, and H. H. Neumayer
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1073 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Bai, J. Liu, Y. Wang, S. Honig, L. Qin, P. Boros, and J. S. Bromberg
L-Selectin-Dependent Lymphoid Occupancy Is Required to Induce Alloantigen-Specific Tolerance
J. Immunol., February 15, 2002; 168(4): 1579 - 1589.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Hammond-McKibben, P. Lake, J. Zhang, N. Tart-Risher, R. Hugo, and M. Weetall
A High-Capacity Quantitative Mouse Model of Drug-Mediated Immunosuppression Based on Rejection of an Allogeneic Subcutaneous Tumor
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1144 - 1151.
[Abstract] [Full Text]

Home page
 J Am Coll CardiolHome page
T. Miyamoto, A. Matsumori, M.-W. Hwang, R. Nishio, H. Ito, and S. Sasayama
Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1713 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Nagahara, M. Ikekita, and T. Shinomiya
Immunosuppressant FTY720 Induces Apoptosis by Direct Induction of Permeability Transition and Release of Cytochrome c from Mitochondria
J. Immunol., September 15, 2000; 165(6): 3250 - 3259.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Sun, R. Taniguchi, D. Tanoue, T. Yamaji, H. Takematsu, K. Mori, T. Fujita, T. Kawasaki, and Y. Kozutsumi
Sli2 (Ypk1), a Homologue of Mammalian Protein Kinase SGK, Is a Downstream Kinase in the Sphingolipid-Mediated Signaling Pathway of Yeast
Mol. Cell. Biol., June 15, 2000; 20(12): 4411 - 4419.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. D. Pinschewer, A. F. Ochsenbein, B. Odermatt, V. Brinkmann, H. Hengartner, and R. M. Zinkernagel
FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory
J. Immunol., June 1, 2000; 164(11): 5761 - 5770.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Yanagawa, K. Sugahara, H. Kataoka, T. Kawaguchi, Y. Masubuchi, and K. Chiba
FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats. II. FTY720 Prolongs Skin Allograft Survival by Decreasing T Cell Infiltration into Grafts But Not Cytokine Production In Vivo
J. Immunol., June 1, 1998; 160(11): 5493 - 5499.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.-J. Shei, D. Card, C. Keohane, et al.
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Science, April 12, 2002; 296(5566): 346 - 349.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.